| Autor: |
Kok M; Departments of Medical Oncology and Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Gielen RJ; Departments of Medical Oncology and Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Adams S; Perlmutter Cancer Center, NYU Langone Health, New York, NY.; Department of Medicine, NYU Grossman School of Medicine, Manhattan, NY., Lennerz JK; BostonGene, Waltham, MA., Sharma P; University of Kansas Medical Center, Westwood, KS., Loibl S; GBG Forschungs GmbH, Neu-Isenburg, Germany.; Centre for Haematology and Oncology, Bethanien, and Goethe University, Frankfurt, Germany., Reardon E; Physician, Patient., Sonke G; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn S; Departments of Medical Oncology and Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Delaloge S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Lacombe D; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Robinson T; Bristol Medical School, University of Bristol, Bristol, United Kingdom., Badve S; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Emory University Winship Cancer Institute, Atlanta, GA., Martin M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Universite Libre de Bruxelles, Bruxelles, Belgium., Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia., Pusztai L; Department of Medicine, Yale Cancer Center, Yale University, New Haven, CT., Tolaney SM; Dana-Farber Cancer Institute, Boston, MA., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Division of Research, PeterMacCallum Cancer Centre, Melbourne, VIC, Australia. |
